An 8 Week Randomized Double Blind Placebo Controlled Multi-site Study Assessing Efficacy and Safety of MYDAYIS® (d-amphetamine / L-amphetamine) for Bipolar Depression
Latest Information Update: 17 Mar 2025
At a glance
- Drugs Mixed amfetamine salts (Primary)
- Indications Bipolar depression; Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 12 Mar 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 12 Mar 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2025.
- 10 Feb 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.